BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16496326)

  • 1. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites.
    Ala A; Stanca CM; Bu-Ghanim M; Ahmado I; Branch AD; Schiano TD; Odin JA; Bach N
    Hepatology; 2006 Mar; 43(3):525-31. PubMed ID: 16496326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Loehe F; Schauer RJ
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):167-74. PubMed ID: 15879622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
    Dyson JK; Blain A; Foster Shirley MD; Hudson M; Rushton S; Jeffreys Jones DE
    JHEP Rep; 2021 Feb; 3(1):100202. PubMed ID: 33474546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
    Silveira MG; Mendes FD; Diehl NN; Enders FT; Lindor KD
    Liver Int; 2009 Aug; 29(7):1094-100. PubMed ID: 19291181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation trends in primary biliary cirrhosis.
    Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in PBC and PSC: indications and disease recurrence.
    Carbone M; Neuberger J
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
    Mattner J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
    Maheshwari A; Yoo HY; Thuluvath PJ
    Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.
    Boonstra K; Beuers U; Ponsioen CY
    J Hepatol; 2012 May; 56(5):1181-1188. PubMed ID: 22245904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation.
    Singal AK; Fang X; Kaif M; Hasanin M; Mcguire BM; Kuo YF; Wiesner RH
    Transpl Int; 2017 May; 30(5):454-462. PubMed ID: 27754570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplantation and autoimmunity.
    Jaeckel E; Tillmann HL; Manns MP
    Acta Gastroenterol Belg; 1999; 62(3):323-9. PubMed ID: 10547899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
    Bloom S; Fleming K; Chapman R
    Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York.
    Smyk D; Mytilinaiou MG; Rigopoulou EI; Bogdanos DP
    Dis Markers; 2010; 29(6):337-44. PubMed ID: 21297253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
    J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestatic Liver Diseases After Liver Transplant.
    Pena Polanco NA; Levy C; Martin EF
    Clin Liver Dis; 2017 May; 21(2):403-420. PubMed ID: 28364821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caroli disease patients have excellent survival after liver transplant.
    Harring TR; Nguyen NT; Liu H; Goss JA; O'Mahony CA
    J Surg Res; 2012 Oct; 177(2):365-72. PubMed ID: 22640887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in autoimmune liver disease--selection of patients.
    Tillmann HL; Jäckel E; Manns MP
    Hepatogastroenterology; 1999; 46(30):3053-9. PubMed ID: 10626159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.